Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hERG (human Ether-a-go-go-Related Gene) potassium channel is crucial for the electrical activity of the heart. It encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel (I_Kr), which plays a key role in cardiac repolarization. Dysfunction or blockage of hERG can lead to Long QT Syndrome (LQTS) and sudden cardiac death. Many drugs have been withdrawn from the market due to their ability to block hERG channels, leading to dangerous arrhythmias. Understanding the structure and function of the hERG channel is crucial for developing safe drugs and for studying cardiac arrhythmias.
hERG channel blockage
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Ether-a-go-go-Related Gene potassium channel (hERG).